TB
Theriva Biologics, Inc.
SEC filingBiotechnology · Rockville, MD
Amount raised$13.1Msold at filing
Total offering$13.1M
Investors in the raise10count reported to the SEC
FiledOct 24, 2025first sale Oct 17, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jeffrey J. KrawsDirector
Jeffrey A. WolfDirector
John J. MonahanDirector
Steven A. ShallcrossExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.